Oddity Technologies (Nasdaq: ODD)

Launched in 2018 by Holtzman and his sister Shiran Holtzman-Erel, Oddity aims to disrupt the legacy beauty market and replace the in-store experience by using data and artificial intelligence to develop brands and make tailored product recommendations.

The company behind Il Makiage will use AI-based molecule discovery, a common tool in pharmaceutical drug development, to target cosmetics pain points like hair loss and aging.

The new molecules will be used in existing Il Makiage and Spoiled Child products.